Page last updated: 2024-11-01

niceritrol and Broad Beta Disease

niceritrol has been researched along with Broad Beta Disease in 1 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kibata, M1
Ishida, M1
Asano, K1
Uehara, H1
Saito, K1
Fuchimoto, T1
Ugaki, K1
Murakami, H1
Matoba, K1
Kotakemori, Y1
Shirai, K1
Yoshioka, H1
Nanba, M1
Yasuda, M1
Ishizaki, M1
Kitagawa, N1
Ikejiri, K1
Inohara, R1
Lee, BJ1
Saino, S1
Sakado, J1
Matuzaka, H1
Numata, K1
Mandai, M1
Miyake, K1
Nakamura, K1

Other Studies

1 other study available for niceritrol and Broad Beta Disease

ArticleYear
Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
    Atherosclerosis, 1980, Volume: 37, Issue:3

    Topics: Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipide

1980